• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For August 15, 2022

    8/15/22 5:30:10 AM ET
    $ABOS
    $ADES
    $ALBO
    $AMPS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Major Chemicals
    Industrials
    Get the next $ABOS alert in real time by email

     

    Companies Reporting Before The Bell

    • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.

    • GreenPower Motor Co (NASDAQ:GP) is estimated to report quarterly loss at $0.15 per share on revenue of $5.59 million.

    • Mondee Hldgs (NASDAQ:MOND) is likely to report quarterly loss at $0.04 per share on revenue of $38.94 million.

    • Reshape Lifesciences (NASDAQ:RSLS) is expected to report quarterly loss at $0.35 per share on revenue of $3.41 million.

    • Alaunos Therapeutics (NASDAQ:TCRT) is expected to report earnings for its second quarter.

    • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $0.19 per share on revenue of $5.25 million.

    • IM Cannabis (NASDAQ:IMCC) is estimated to report quarterly earnings at $0.01 per share on revenue of $20.60 million.

    • Wejo Gr (NASDAQ:WEJO) is expected to report earnings for its second quarter.

    • Impel Pharmaceuticals (NASDAQ:IMPL) is likely to report quarterly loss at $1.05 per share on revenue of $3.83 million.

    • TherapeuticsMD (NASDAQ:TXMD) is expected to report quarterly loss at $3.04 per share on revenue of $23.20 million.

    • SPDR Select Sector Fund - Consumer Discretionary (NYSE:XLY) is likely to report quarterly loss at $0.01 per share on revenue of $25.70 million.

    • SCYNEXIS (NASDAQ:SCYX) is expected to report earnings for its second quarter.

    • Medicenna Therapeutics (NASDAQ:MDNA) is likely to report earnings for its first quarter.

    • Roivant Sciences (NASDAQ:ROIV) is projected to report earnings for its first quarter.

    • Fathom Digital Mfg (NYSE:FATH) is expected to report quarterly loss at $0.01 per share on revenue of $43.46 million.

    • Gamida Cell (NASDAQ:GMDA) is likely to report earnings for its second quarter.

    • Viridian Therapeutics (NASDAQ:VRDN) is projected to report quarterly loss at $0.90 per share on revenue of $230 thousand.

    • Protalix BioTherapeutics (AMEX:PLX) is projected to report earnings for its second quarter.

    • ATAI Life Sciences (NASDAQ:ATAI) is expected to report earnings for its second quarter.

    • Stran & Co (NASDAQ:STRN) is projected to report earnings for its second quarter.

    • Li Auto (NASDAQ:LI) is projected to report quarterly loss at $0.06 per share on revenue of $1.12 billion.

    • Celsion (NASDAQ:CLSN) is estimated to report quarterly loss at $1.12 per share on revenue of $80 thousand.

    • CBAK Energy Tech (NASDAQ:CBAT) is estimated to report earnings for its second quarter.

    • Rockwell Medical (NASDAQ:RMTI) is projected to report earnings for its second quarter.

    • Stratus Properties (NASDAQ:STRS) is projected to report earnings for its second quarter.

    • Harbor Custom Dev (NASDAQ:HCDI) is expected to report quarterly earnings at $0.01 per share on revenue of $34.05 million.

    • Inuvo (AMEX:INUV) is projected to report quarterly loss at $0.01 per share on revenue of $20.05 million.

    • Stryve Foods (NASDAQ:SNAX) is expected to report quarterly loss at $0.33 per share on revenue of $13.45 million.

    • AEye (NASDAQ:LIDR) is likely to report quarterly loss at $0.15 per share on revenue of $830 thousand.

    • Sterling Bancorp (NASDAQ:SBT) is projected to report earnings for its second quarter.

    • Altus Power (NYSE:AMPS) is estimated to report earnings for its second quarter.

    • Weber (NYSE:WEBR) is estimated to report earnings for its third quarter.

    • WiSA Technologies (NASDAQ:WISA) is estimated to report earnings for its second quarter.

    • Gracell Biotechnologies (NASDAQ:GRCL) is estimated to report earnings for its second quarter.

    • Brainstorm Cell (NASDAQ:BCLI) is projected to report earnings for its second quarter.

    • Clear Secure (NYSE:YOU) is expected to report earnings for its second quarter.

    • Embecta (NASDAQ:EMBC) is expected to report quarterly earnings at $0.87 per share on revenue of $276.86 million.

    • Thoughtworks Holding (NASDAQ:TWKS) is likely to report quarterly earnings at $0.11 per share on revenue of $328.34 million.

    • Niu Technologies (NASDAQ:NIU) is projected to report earnings for its second quarter.

    • DouYu Intl Hldgs (NASDAQ:DOYU) is expected to report quarterly loss at $0.04 per share on revenue of $263.99 million.

    • UpHealth (NYSE:UPH) is projected to report quarterly loss at $0.08 per share on revenue of $45.00 million.

    • Gelesis Holdings (NYSE:GLS) is likely to report earnings for its second quarter.

    • Kalera (NASDAQ:KAL) is projected to report earnings for its second quarter.

    • Bitfarms (NASDAQ:BITF) is projected to report earnings for its second quarter.

    Companies Reporting After The Bell

    • Acumen Pharmaceuticals (NASDAQ:ABOS) is estimated to report earnings for its second quarter.

    • Vivos Therapeutics (NASDAQ:VVOS) is projected to report earnings for its second quarter.

    • GSE Systems (NASDAQ:GVP) is estimated to report earnings for its second quarter.

    • Navitas Semiconductor (NASDAQ:NVTS) is likely to report quarterly loss at $0.09 per share on revenue of $8.42 million.

    • Neptune Wellness Solns (NASDAQ:NEPT) is estimated to report quarterly loss at $2.45 per share on revenue of $18.00 million.

    • Tivic Health Systems (NASDAQ:TIVC) is projected to report earnings for its second quarter.

    • mCloud Technologies (NASDAQ:MCLD) is estimated to report earnings for its second quarter.

    • Biotricity (NASDAQ:BTCY) is estimated to report quarterly loss at $0.11 per share on revenue of $2.19 million.

    • Assure Hldgs (NASDAQ:IONM) is expected to report quarterly loss at $0.23 per share on revenue of $6.08 million.

    • Dolphin Entertainment (NASDAQ:DLPN) is projected to report quarterly earnings at $0.08 per share on revenue of $10.30 million.

    • iSun (NASDAQ:ISUN) is expected to report earnings for its second quarter.

    • Phoenix New Media (NYSE:FENG) is expected to report earnings for its second quarter.

    • Icecure Medical (NASDAQ:ICCM) is estimated to report earnings for its first quarter.

    • Stronghold Digital Mining (NASDAQ:SDIG) is projected to report earnings for its second quarter.

    • CVD Equipment (NASDAQ:CVV) is projected to report earnings for its second quarter.

    • Amtech Systems (NASDAQ:ASYS) is estimated to report quarterly loss at $0.28 per share on revenue of $14.72 million.

    • Quipt Home Medical (NASDAQ:QIPT) is expected to report earnings for its third quarter.

    • Blend Labs (NYSE:BLND) is projected to report quarterly loss at $0.19 per share on revenue of $58.32 million.

    • Verb Tech (NASDAQ:VERB) is likely to report quarterly loss at $0.06 per share on revenue of $2.93 million.

    • Midwest Holding (NASDAQ:MDWT) is projected to report quarterly loss at $0.21 per share on revenue of $10.40 million.

    • Greenidge Generation Hldg (NASDAQ:GREE) is expected to report quarterly loss at $0.12 per share on revenue of $46.10 million.

    • Enthusiast Gaming (NASDAQ:EGLX) is estimated to report quarterly loss at $0.09 per share on revenue of $50.26 million.

    • Kubient (NASDAQ:KBNT) is estimated to report quarterly loss at $0.22 per share on revenue of $1.20 million.

    • INVO Bioscience (NASDAQ:INVO) is likely to report quarterly loss at $0.24 per share on revenue of $330 thousand.

    • Biora Therapeutics (NASDAQ:BIOR) is estimated to report earnings for its second quarter.

    • Creative Realities (NASDAQ:CREX) is estimated to report earnings for its second quarter.

    • Arcimoto (NASDAQ:FUV) is estimated to report quarterly loss at $0.30 per share on revenue of $2.25 million.

    • F45 Training Holdings (NYSE:FXLV) is expected to report quarterly earnings at $0.14 per share on revenue of $50.17 million.

    • HyreCar (NASDAQ:HYRE) is expected to report quarterly loss at $0.25 per share on revenue of $10.46 million.

    • Blackboxstocks (NASDAQ:BLBX) is likely to report quarterly loss at $0.08 per share on revenue of $1.45 million.

    • Ginkgo Bioworks Holdings (NYSE:DNA) is likely to report quarterly loss at $0.04 per share on revenue of $77.63 million.

    • Ferroglobe (NASDAQ:GSM) is estimated to report quarterly earnings at $0.84 per share on revenue of $738.10 million.

    • SpringBig Holdings (NASDAQ:SBIG) is expected to report quarterly loss at $0.21 per share on revenue of $7.20 million.

    • Recruiter.Com Group (NASDAQ:RCRT) is likely to report quarterly loss at $0.25 per share on revenue of $7.20 million.

    • Sanara MedTech (NASDAQ:SMTI) is estimated to report earnings for its second quarter.

    • Sunlight Finl Hldgs (NYSE:SUNL) is expected to report quarterly earnings at $0.05 per share on revenue of $34.52 million.

    • Field Trip Health (NASDAQ:FTRP) is estimated to report quarterly loss at $0.16 per share on revenue of $1.79 million.

    • Fluence Energy (NASDAQ:FLNC) is likely to report quarterly loss at $0.34 per share on revenue of $227.93 million.

    • FiscalNote Holdings (NYSE:NOTE) is projected to report quarterly loss at $0.44 per share on revenue of $29.14 million.

    • Cemtrex (NASDAQ:CETX) is expected to report earnings for its third quarter.

    • Calithera Biosciences (NASDAQ:CALA) is expected to report earnings for its second quarter.

    • Immersion (NASDAQ:IMMR) is likely to report earnings for its second quarter.

    • American Res (NASDAQ:AREC) is estimated to report earnings for its second quarter.

    • Grupo Televisa (NYSE:TV) is projected to report quarterly loss at $0.03 per share on revenue of $68.84 million.

    • Charah Solns (NYSE:CHRA) is likely to report quarterly loss at $0.21 per share on revenue of $79.48 million.

    • TMC Metals (NASDAQ:TMC) is estimated to report earnings for its third quarter.

    • Nu Holdings (NYSE:NU) is expected to report earnings for its second quarter.

    • Advanced Emissions Solns (NASDAQ:ADES) is likely to report earnings for its second quarter.

    • Flexible Solutions Intl (AMEX:FSI) is estimated to report quarterly earnings at $0.07 per share on revenue of $9.55 million.

    • Fabrinet (NYSE:FN) is projected to report quarterly earnings at $1.54 per share on revenue of $581.50 million.

    • KULR Tech Gr (AMEX:KULR) is estimated to report quarterly loss at $0.03 per share on revenue of $880 thousand.

    • Gold Royalty (AMEX:GROY) is projected to report earnings for its third quarter.

    • AMMO (NASDAQ:POWW) is expected to report earnings for its first quarter.

    • Ideal Power (NASDAQ:IPWR) is estimated to report quarterly loss at $0.29 per share on revenue of $200 thousand.

    • Iridex (NASDAQ:IRIX) is projected to report quarterly loss at $0.15 per share on revenue of $13.92 million.

    • Duos Technologies Group (NASDAQ:DUOT) is projected to report quarterly loss at $0.26 per share on revenue of $2.70 million.

    • Nerdy (NYSE:NRDY) is likely to report earnings for its second quarter.

    • T2 Biosystems (NASDAQ:TTOO) is projected to report earnings for its second quarter.

    • GoHealth (NASDAQ:GOCO) is expected to report quarterly loss at $0.21 per share on revenue of $130.21 million.

    • Accelerate Diagnostics (NASDAQ:AXDX) is projected to report quarterly loss at $0.28 per share on revenue of $3.00 million.

    • CuriosityStream (NASDAQ:CURI) is expected to report quarterly loss at $0.28 per share on revenue of $20.99 million.

    • ThredUp (NASDAQ:TDUP) is projected to report earnings for its second quarter.

    • aTyr Pharma (NASDAQ:LIFE) is likely to report quarterly loss at $0.38 per share on revenue of $2.00 million.

    • Lucira Health (NASDAQ:LHDX) is likely to report quarterly loss at $0.34 per share on revenue of $30.05 million.

    • GreenBox POS (NASDAQ:GBOX) is likely to report quarterly loss at $0.20 per share on revenue of $5.66 million.

    • ENDRA Life Sciences (NASDAQ:NDRA) is likely to report earnings for its second quarter.

    • Peraso (NASDAQ:PRSO) is likely to report earnings for its second quarter.

    • Transphorm (NASDAQ:TGAN) is likely to report earnings for its first quarter.

    • Shoals Technologies Gr (NASDAQ:SHLS) is expected to report earnings for its second quarter.

    • Bird Glb (NYSE:BRDS) is estimated to report quarterly loss at $0.13 per share on revenue of $80.96 million.

    • Miromatrix Medical (NASDAQ:MIRO) is likely to report earnings for its second quarter.

    • Pioneer Power Solutions (NASDAQ:PPSI) is projected to report earnings for its second quarter.

    • WidePoint (AMEX:WYY) is expected to report earnings for its second quarter.

    • CYREN (NASDAQ:CYRN) is estimated to report earnings for its second quarter.

    • Remark Hldgs (NASDAQ:MARK) is projected to report earnings for its second quarter.

    • Quest Resource Holding (NASDAQ:QRHC) is projected to report earnings for its second quarter.

    • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for its second quarter.

    • IZEA Worldwide (NASDAQ:IZEA) is estimated to report quarterly loss at $0.02 per share on revenue of $9.75 million.

    • Agora (NASDAQ:API) is estimated to report quarterly loss at $0.20 per share on revenue of $40.08 million.

    • Albireo Pharma (NASDAQ:ALBO) is estimated to report quarterly loss at $1.65 per share on revenue of $7.45 million.

    • CohBar (NASDAQ:CWBR) is likely to report earnings for its second quarter.

    • GAN (NASDAQ:GAN) is expected to report quarterly loss at $0.13 per share on revenue of $36.47 million.

    • Compass (NYSE:COMP) is expected to report quarterly loss at $0.14 per share on revenue of $2.12 billion.

    • Sema4 Holdings (NASDAQ:SMFR) is estimated to report earnings for its second quarter.

    • SomaLogic (NASDAQ:SLGC) is likely to report quarterly loss at $0.18 per share on revenue of $24.82 million.

    • Zenvia (NASDAQ:ZENV) is likely to report earnings for its second quarter.

    • IonQ (NYSE:IONQ) is likely to report quarterly loss at $0.10 per share on revenue of $2.39 million.

    • Urban-gro (NASDAQ:UGRO) is likely to report earnings for its second quarter.

    • SkyWater Technology (NASDAQ:SKYT) is estimated to report earnings for its second quarter.

    • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.07 per share on revenue of $1.23 billion.

    • ZipRecruiter (NYSE:ZIP) is projected to report quarterly earnings at $0.06 per share on revenue of $234.81 million.

    • Intercorp Financial Servs (NYSE:IFS) is likely to report quarterly earnings at $0.76 per share on revenue of $295.00 million.

    • Vicinity Motor (NASDAQ:VEV) is expected to report earnings for its second quarter.

    • Yunhong CTI (NASDAQ:CTIB) is likely to report earnings for its second quarter.

    • Burcon NutraScience (NASDAQ:BRCN) is likely to report earnings for its first quarter.

    • Panbela Therapeutics (NASDAQ:PBLA) is likely to report earnings for its second quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ABOS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABOS
    $ADES
    $ALBO
    $AMPS

    CompanyDatePrice TargetRatingAnalyst
    Fluence Energy Inc.
    $FLNC
    2/10/2026$24.00Hold → Buy
    Jefferies
    Li Auto Inc.
    $LI
    2/9/2026$14.00Neutral → Underweight
    Analyst
    Fabrinet
    $FN
    2/4/2026$540.00Peer Perform → Outperform
    Wolfe Research
    Compass Inc.
    $COMP
    1/27/2026$14.00Neutral
    Goldman
    Bitfarms Ltd.
    $BITF
    1/27/2026$3.00Outperform → Mkt Perform
    Keefe Bruyette
    Compass Inc.
    $COMP
    1/26/2026$15.00Overweight
    Analyst
    Li Auto Inc.
    $LI
    1/23/2026$17.50Buy → Hold
    Jefferies
    Gold Royalty Corp.
    $GROY
    1/22/2026Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Donnell Paul covered exercise/tax liability with 44 shares, decreasing direct ownership by 0.13% to 34,311 units (SEC Form 4)

    4 - FiscalNote Holdings, Inc. (0001823466) (Issuer)

    2/11/26 7:28:40 PM ET
    $NOTE
    Real Estate

    Director Yao Gerald covered exercise/tax liability with 42 shares (SEC Form 4)

    4 - FiscalNote Holdings, Inc. (0001823466) (Issuer)

    2/11/26 7:28:20 PM ET
    $NOTE
    Real Estate

    Chief Legal & Admin. Officer Aman Todd covered exercise/tax liability with 67 shares, decreasing direct ownership by 0.08% to 79,703 units (SEC Form 4)

    4 - FiscalNote Holdings, Inc. (0001823466) (Issuer)

    2/11/26 7:27:58 PM ET
    $NOTE
    Real Estate

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer O'Dowd William Iv bought $4,920 worth of shares (3,000 units at $1.64), increasing direct ownership by 0.69% to 434,690 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/11/26 4:38:15 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Chief Financial Officer Dizon Romeo R bought $1,460 worth of shares (1,000 units at $1.46), increasing direct ownership by 0.87% to 116,190 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/10/26 3:19:41 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chief Financial Officer Dizon Romeo R bought $3,450 worth of shares (2,500 units at $1.38), increasing direct ownership by 2% to 115,190 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/3/26 6:21:19 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ABOS
    $ADES
    $ALBO
    $AMPS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    April 17, 2023 - FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

    For Immediate Release: April 17, 2023 Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers p

    4/17/23 1:02:15 PM ET
    $GMDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FiscalNote Announces Major Expansion Into Political Prediction Markets

    Unveils Political Predictions Preview Site Enters Into Strategic Partnership Memorandum of Understanding (MOU) with Prediction Market Technology Company 365Prediction Engages Industry-Leading Expert Dr. Laila Mintas to Support Go-to-Market Execution Targets a Rapidly Scaling Opportunity as Prediction Market Trading Volumes and Adoption Continue to Accelerate FiscalNote Holdings, Inc. (NYSE:NOTE), a global leader in AI-driven policy and regulatory intelligence, today announced a major expansion into the rapidly growing political prediction market, a category attracting increased attention as interest in outcome-based forecasting accelerates. The Company has introduced a preview

    2/12/26 7:04:00 AM ET
    $NOTE
    Real Estate

    Rockwell Medical Named 'Great Place to Work' for Fourth Year in a Row

    Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company has been certified as a Great Place to Work® for the fourth year in a row. "Being recognized as a Great Place to Work for four consecutive years underscores that our people are the foundation of our success. Their dedication, passion, and commitment to our mission and values shape the culture that sets us apart," said Lesley Spriggs, Vice President of Human Resources at Rockwell Medical. "This achievement motivates us to continue fostering an environment

    2/12/26 6:00:00 AM ET
    $RMTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    embecta names new Chairman of the Board and Lead Independent Director

    PARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that the Board of Directors (the "Board") of embecta has elected Devdatt "Dev" Kurdikar as Chairman of the Board and Dr. Claire Pomeroy as Lead Independent Director, effective immediately. These changes follow the previously announced retirement of LTG (Ret.) David F. Melcher, Non-Executive Chairman of the Board due to several commitments outside of his service to the Company. Kurdikar, 57, joined BD (Becton, Dickinson and Company) in 2021 to lead the diabete

    2/11/26 4:10:00 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Fluence upgraded by Jefferies with a new price target

    Jefferies upgraded Fluence from Hold to Buy and set a new price target of $24.00

    2/10/26 7:57:53 AM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    Li Auto downgraded by Analyst with a new price target

    Analyst downgraded Li Auto from Neutral to Underweight and set a new price target of $14.00

    2/9/26 7:00:29 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Fabrinet upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Fabrinet from Peer Perform to Outperform and set a new price target of $540.00

    2/4/26 8:55:11 AM ET
    $FN
    Telecommunications Equipment
    Utilities

    $ABOS
    $ADES
    $ALBO
    $AMPS
    SEC Filings

    View All

    SEC Form EFFECT filed by IM Cannabis Corp.

    EFFECT - IM Cannabis Corp. (0001792030) (Filer)

    2/12/26 12:15:26 AM ET
    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care

    Protalix BioTherapeutics Inc. (DE) filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Protalix BioTherapeutics, Inc. (0001006281) (Filer)

    2/11/26 5:10:47 PM ET
    $PLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by ThredUp Inc.

    SCHEDULE 13G/A - ThredUp Inc. (0001484778) (Subject)

    2/11/26 4:45:10 PM ET
    $TDUP
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Financials

    Live finance-specific insights

    View All

    Local Bounti Receives Continued Listing Standard Notice from NYSE

    HAMILTON, Mont., Feb. 11, 2026 /PRNewswire/ -- Local Bounti Corporation (NYSE:LOCL) ("Local Bounti" or the "Company"), a breakthrough U.S. indoor agriculture company, today announced that on February 5, 2026, it received a notice (the "Notice") from the New York Stock Exchange (the "NYSE") that it is not in compliance with the NYSE continued listing standards set forth in Section 802.01B of the NYSE Listed Company Manual (the "Minimum Market Capitalization Standard") due to the fact that the Company's average global market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, its stockholders' equity was less than $50 million.

    2/11/26 4:05:00 PM ET
    $LOCL
    Farming/Seeds/Milling
    Consumer Staples

    Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA

    REDWOOD CITY, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), an innovative Technology-as-a-Service (TaaS) company committed to transforming chronic condition detection and management with state-of-the-art remote patient monitoring solutions, today announced its financial results for its third quarter of fiscal 2026, ended December 31, 2025. Continuing its strong record of scalable revenue, the Company reported sustained revenue growth driven by increasing adoption of its remote cardiac monitoring solutions and improving operating efficiency. Dr. Waqaas Al-Siddiq, Biotricity Founder & CEO, said, "The need for proactive chronic care manag

    2/11/26 4:00:00 PM ET
    $BTCY
    Medical/Dental Instruments
    Health Care

    Tencent Music Entertainment Group to Report Fourth Quarter and Full Year 2025 Financial Results on March 17, 2026

    SHENZHEN, China, Feb. 10, 2026 /PRNewswire/ -- Tencent Music Entertainment Group ("TME", or the "Company") (NYSE:TME), the leading online music and audio entertainment platform in China, today announced that it will report its unaudited financial results for the fourth quarter and full year of 2025 before the U.S. market opens on Tuesday, March 17, 2026. TME's management will host a Tencent Meeting Webinar on Tuesday, March 17, 2026, at 7:00 A.M. Eastern Time or 7:00 P.M. Beijing/Hong Kong Time on Tuesday, March 17, 2026, to review and discuss the Company's business and financial performance. For participants who wish to join the Tencent Meeting Webinar, please complete online registration

    2/10/26 5:00:00 AM ET
    $TME
    Broadcasting
    Consumer Discretionary

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Leadership Updates

    Live Leadership Updates

    View All

    ZipRecruiter Announces Board of Directors Appointment

    ZipRecruiter® (NYSE:ZIP), a leading online employment marketplace, today announced the appointment of Jennifer Saenz to the company's Board of Directors (the "Board") and the resignation of Yvonne Hao from her position as a member of the Board, both effective February 5, 2026. Jennifer Saenz will also serve as a member of ZipRecruiter's Compensation Committee and Nominating and Corporate Governance Committee. "Jennifer has spent her career building trusted brands and operating at scale, and we're thrilled to welcome her to our Board," said Ian Siegel, CEO of ZipRecruiter. "Her experience leading marketing, merchandising, and commerce organizations will be valuable as we continue to improv

    2/9/26 6:30:00 PM ET
    $ZIP
    Computer Software: Programming Data Processing
    Technology

    IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved

    Ronen Tsimerman will continue as CFO until successor is appointed CAESAREA, Israel, Feb. 9, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that after nearly a decade of service with IceCure, Chief Financial Officer Ronen Tsimerman has informed the Company of his decision to leave the Company to pursue new opportunities. The Company has initiated a search for a new Chief Financial Officer and has identified compelling candidates with significant experience commercializing disruptive technolo

    2/9/26 4:30:00 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REalloys, to Appoint General Jack Keane to its Board of Directors

    General Keane, a Four-Star General (Ret), Joins REalloys on its Mission to Scale North-America's Most Advanced Heavy Rare Earth Supply Chain & Technology Platform REalloys' Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close its merger with Blackboxstocks, Inc. (NASDAQ:BLBX) DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has appointed General John M. "Jack" Keane (U.S. Army, Ret.) as a Designate Director. General Keane will formally join the Board of Directors upon the closing of the merger b

    2/9/26 8:30:00 AM ET
    $BLBX
    EDP Services
    Technology

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Quipt Home Medical Corp.

    SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:07:36 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Quipt Home Medical Corp.

    SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:42 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Quipt Home Medical Corp.

    SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:09 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary